Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Retatrutide is a single molecule activating three hormone receptors (GLP-1, GIP, glucagon)
Currently, many health insurance plans, as well Medicare, only cover GLP-1 treatment for diabetes
CAS Number 2381089-83-2 Molecular Formula C221H342N46O68 Molecular Weight 4731.4 g/mol Half-Life ~6 days (research reports) Sources & References Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial Jastreboff AM, et al
GHK-Cu has been studied for its potential relevance to connective tissue and extracellular matrix regulation in cell and tissue models, while TB-500 and BPC-157 have been investigated in preclinical systems involving soft tissue, tendon and ligament models, and angiogenesis related signaling
Oxidative stress and cardiovascular injury: Part II: Animal and human studies
US$ 22.41
US$ 28.13
US$ 25.28
US$ 25.04
US$ 24.33
